Showing 1 - 6 results of 6 for search 'Karoline Lerang', query time: 0.03s Refine Results
  1. 1
    O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway

    O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway by Øyvind Molberg, Sella A Provan, Karoline Lerang, Cathrine Brunborg, Hilde Haukeland, Sigrid R Moe, Torild Garen, Antonela Botea, Anniken Orre, Heidi Øvreås, Thea Bøe, Gro Å Wivestad, Nenad Damjanic

    Published 2024-03-01
    Article
  2. 2
    Sensitivity of classification criteria from time of diagnosis in an incident systemic lupus erythematosus cohort: a population-based study from Norway

    Sensitivity of classification criteria from time of diagnosis in an incident systemic lupus erythematosus cohort: a population-based study from Norway by Øyvind Molberg, Karoline Lerang, Cathrine Brunborg, Hilde Haukeland, Helga Sanner, Antonela Botea, Anniken Orre, Nenad Damjanic, Sigrid Reppe Moe, Gro Årthun Wivestad, Heidi Kverneggen Øvreås, Thea Bjerkestrand Bøe, Garen Torhild

    Published 2024-08-01
    Get full text
    Article
  3. 3
    P77 Identification of a cluster of SLE risk loci associated with levels of multiple blood biomarkers in the general population – Implication for SLE sub-phenotypes

    P77 Identification of a cluster of SLE risk loci associated with levels of multiple blood biomarkers in the general population – Implication for SLE sub-phenotypes by Lars Rönnblom, Andreas Jönsen, Sarah Reid, Christopher Sjöwall, Solbritt Rantapää-Dahlqvist, Øyvind Molberg, Dag Leonard, Maija-Leena Eloranta, Martina Frodlund, Anders A Bengtsson, Karoline Lerang, Anna Rudin, Ahmed Sayadi, Nina Oparina

    Published 2024-03-01
    Article
  4. 4
    O4 Clinical characteristics of patients with high SLE-specific and high multitrait polygenic risk – An investigation of SLE risk loci

    O4 Clinical characteristics of patients with high SLE-specific and high multitrait polygenic risk – An investigation of SLE risk loci by Lars Rönnblom, Andreas Jönsen, Sarah Reid, Christopher Sjöwall, Solbritt Rantapää-Dahlqvist, Øyvind Molberg, Dag Leonard, Maija-Leena Eloranta, Martina Frodlund, Anders A Bengtsson, Karoline Lerang, Anna Rudin, Ahmed Sayadi, Nina Oparina

    Published 2024-03-01
    Article
  5. 5
    B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus

    B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus by Andreas Jönsen, Sarah Reid, Christopher Sjöwall, Solbritt Rantapää-Dahlqvist, Øyvind Molberg, Dag Leonard, Maija-Leena Eloranta, Johanna K Sandling, Martina Frodlund, Karin Bolin, Anders A Bengtsson, Karoline Lerang, Anna Rudin, Anna Hedenstedt, Ahmed Sayadi, Elisabeth Skoglund

    Published 2023-10-01
    Get full text
    Article
  6. 6
    A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome

    A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome by Xavier Mariette, Francesca Barone, Chiara Baldini, Hendrika Bootsma, Kenneth L. Clark, Salvatore De Vita, David H. Gardner, Robert B. Henderson, Michael Herdman, Karoline Lerang, Prafull Mistry, Raj Punwaney, Raphaele Seror, John Stone, Paul L.A. van Daele, André van Maurik, Nicolas Wisniacki, David A. Roth, Paul Peter Tak

    Published 2022-12-01
    Get full text
    Article

Search Tools: